Drug Information

• Alerts
• National Drug Shortages
• RxWebLinks
• Medical Service Reps

Alerts

• Home
• Sort Alphabetically
• Sound Alike / Look Alike

Pharmacy Services

Latest drug alerts and warnings

Sorted Alphabetically

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

• 5-alpha Reductase Inhibitors (5-ARIs) Label Update - Increased Risk of Prostate Cancer - 6/13/2011
• Abacavir (Ziagen) and Abacavir-Containing Medications - Patient Screening Recommended - 7/29/2008
• Abacavir and Didanosine and Potential Risk of Heart Attack - Ongoing Safety Review - 3/7/2011
• Abacavir Sulfate (Ziagen) and Lamivudine/Zidovudine (Combivir) - Third Party Tampering - 4/12/2007
• Abacus Total Parenteral Nutrition (TPN) Calculation Software from Baxa – Class I Recall Due to Potential for Dosing Errors - 5/29/2012
• Abbott Blood Glucose Meter Display Problems - 9/13/2007
• Abbott Glucose Test Strips - Recall Due to Incorrect Results - 12/23/2010
• Able Laboratories Inc. - Recalls All Products/Suspends Manufacturing - 10/8/2009
• ACCU-CHEC glucose meter device recall - 1/23/2006
• ACCU-CHEK Softclix Lancet Recall - 6/3/2009
• Accusure Insulin Syringe Recalld - 10/28/2009
• Accutane and Generic Isotretinoin - iPLEDGE Risk Management Program Modification - 10/12/2006
• Acetaminophen - FDA Actions to Prevent Overdose - 7/1/2009
• Acetaminophen (Tylenol®) Pediatric Liquid Products Recalled Due to Possible Bacterial Contamination - 10/1/2009
• Acetaminophen 500 mg Tablets (Store Brands) - Recall - 11/10/2006
• Acetaminophen Concentrated Drops - Brookstone Pharmaceuticals Voluntary Recall Due to Packaging Concerns - 7/16/2009
• Acetaminophen in Prescription Medications Limited to 325 mg per Dosage Unit - 1/13/2011
• Acetylcysteine Injection (Acetadote) - Recall Due to Particulates - 1/3/2011
• Actavis Drug Recall - 8/5/2008
• Actavis Totowa Digoxin (Digitek®) Recall - 4/29/2008
• Actiq (fentanyl transmucosal) lozenges – breaking or shattering during use - 9/3/2003
• Adalimumab (Humira) and infections/hypersensitivity/and hematologic reaction - 11/9/2004
• Adderall (amphetamine/dextroamphetamine) 30 mg Tablets – Counterfeit Products Sold Containing Acetaminophen and Tramadol - 5/30/2012
• Ado-Trastuzumab (Kadcyla) - Sound-Alike Look-Alike Confusion with Trastuzumab (Herceptin) - 5/8/2013
• Advair Diskus (Fluticasone Propionate and Salmeterol Powder for Inhalation) Stolen - Verify Drug Pedigrees - 7/19/2010
• Advanced Medical Optics Contact Lens Solution Recall - 5/30/2007
• Advanced Medical Optics Recall - Healon D Ophthalmic Viscosurgical Device - 12/12/2008
• Adverse Effects of NSAIDs - Valdecoxib withdrawn/labeling changes for all NSAIDs - 4/7/2005
• Aidapack Services - Recall of Repackaged Products Due To Possible Beta-Lactam Cross Contamination - 6/6/2011
• Alaris CareFusion PC Unit – Recall Due to Error Code - 8/3/2012
• Alaris CareFusion Pump - Recalls - 08/27/2012
• Alaris PC Unit Software V9.12 used with EtCO2 Modules or SpO2 Modules – Class I Recall - 4/23/2013
• Alaris System Class I Recall - 8/7/2009
• Albumin considered safe for use in critically ill patients - 5/20/2005
• Albuterol Inhaler (Ventolin HFA) Recalled by GlaxoSmithKline – May Contain Insufficient Propellant - 1/24/2012
• Albuterol Sulfate 0.083% Inhalation Solution by Ritedose Corporation - Recall Due to Mislabeled Vials - 1/4/2011
• Alcohol Prep Pads, Swabs, and Swabsticks - Recall Due to Possible Microbial Contamination - 2/17/2011
• Alcohol-Free Mouthwash - Recall - 5/7/2008
• Alefacept (Amevive) not recommended for HIV patients - 11/15/2005
• Alemtuzumab (Campath) Associated with Severe Idiopathic Thrombocytopenic Purpura in Multiple Sclerosis Trials - 12/2/2005
• Alglucosidase Alfa (Myozyme) - Formation of Black Particles During Reconstitution - 4/12/2007
• Aliskiren-Containing Blood Pressure Medications: New Contraindication and Warning - 4/23/2012
• Alka-Seltzer Plus Day & Night Cold Formula - Recall of a Single Lot by Bayer Consumer Care - 12/9/2009
• Altocor® (lovastatin extended release) withdrawal/replaced by Altoprev® - 8/11/2004
• Amantadine (Symmetrel, generic) and Rimantadine (Flumadine, generic) - High Levels of Resistance By Influenza A H3N2 Viruses - 1/19/2006
• Ameridose, LLC Voluntarily Recalls All Products - 11/01/2012
• Amicar (aminocaproic acid) and Omacor (omega-3-acid ethyl esters) Dispensing Errors - 3/2/2006
• Amiodarone hydrochloride tablets (Cordarone®/generic) - Patient Medication Guide Requirement - 1/13/2005
• Ammonul (sodium phenylacetate and sodium benzoate) Injection - Filter Required - 9/25/2008
• Amphetamine/Dextroamphetamine (Adderall/Adderall XR)associated with sudden death/sales suspended on Canadian market - 2/10/2005
• Anagrelide (Agrylin) exposure increased in patients with hepatic impairment, contraindicated in severe hepatic impairment - 2/10/2005
• Angiotensin Receptor Blockers and Safety Review for Cancer Risk - 6/3/2011
• Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) Associated with Birth Defects in First Trimester - 6/9/2006
• Anticoagulant Citrate Phosphate Dextrose Solution, USP(CPD) Blood-Pack Unit Recall Due to Incorrect Labeling - 5/2/2013
• Antidepressant labeling changes - 7/6/2004
• Antidepressants and Suicidality in Adults to be Evaluated - 7/1/2005
• Antidepressants and suicidality in children: FDA requests labeling change - 10/15/2004
• Antidepressants and Suicidality in Young Adults - 5/7/2007
• Antiepileptic Drugs and Increased Risk of Suicidal Behavior or Suicidal Ideation - 5/6/2009
• Antipsychotic Class Labeling Update: Pregnancy Sections Revised to Include Risk of Extrapyramidal Signs and Withdrawal Symptoms in Newborns - 2/23/2011
• Anti-Tumor Necrosis Factor (TNF) Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade], golimumab [Simponi]) -Ongoing Safety Review of Malignancy Risk - 11/4/2011
• Anti-Tumor Necrosis Factor (TNF) Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade], golimumab [Simponi]), azathioprine, and mercaptopurine - Reports of Hepatosplenic T-Cell Lymphoma - 11/4/2011
• ApothéCure Recalls All Sterile Compounded Injectables Due to Concerns Regarding Sterility and Quality Control - 04/18/2013
• Aprotinin (Trasylol) Marketing Temporarily Suspended Pending Ongoing Safety Review - 11/5/2007
• Aprotinin (Trasylol): Increased Risk Of Myocardial Infarction/Stroke/Renal Dysfunction/and Anaphylaxis - 12/18/2006
• Aranesp (darbepoetin alfa) and Adverse Effects with Off-Label Dosing - 1/14/2005
• Arava (leflunomide) associated with severe infections and potentially fatal hepatic injury - 11/21/2003
• Argatroban Injection 50 mg/50mL - Voluntary Recall Due To Particulate Matter - 3/23/2012
• Artriphen Recalled by Xymogen due to Undeclared Milk and Soy Content - 5/10/2013
• Asenapine and Serious Hypersensitivity Reactions - 9/2/2011
• Astellas Recall of Lots of Several Medications Due to Stolen Transport Trailer - 7/23/2009
• Atomoxetine (Strattera) - Increased Risk of Suicidal Ideation in Pediatric Patients - 10/3/2005
• Atomoxetine (Strattera) associated with liver toxicity - 12/22/2004
• Atorvastatin Tablets Recalled by Ranbaxy Pharmaceuticals Inc. – May Contain Small Glass Particles - 11/29/2012
• Atypical Antipsychotics - increased mortality in elderly patients with dementia - 4/12/2005
• Atypical antipsychotics and hyperglycemia — Aripiprazole (Abilify) clozapine (Clozaril), olanzapine (Zyprexa), quetiapine (Seroquel), risperidone (Risperdal), and ziprasidone (Geodon) - 9/1/2004
• Automix Automated Nutrition Compounder Class I Recall: Potential for Fluid into Device Keypads - 8/31/2012
• Avastin (bevacizumab) increased risk of arterial thromboembolic events - 1/5/2005
• Avastin® (bevacizumab) - FDA Proposes Removal of Breast Cancer Indication - 12/20/2010
• Azithromycin (Zithromax®) – Risk of Arrhythmia and Cardiovascular Death – Updated - 03/15/2013
• B. Braun Recalls Infusomat Space Infusion System - 8/2/2012
• B. Braun Normal Saline Flush Recall - 9/19/2007
• Baby's Bliss Gripe Water by MOM Enterprises Recalled - 9/28/2007
• Bacteriostatic Sodium Chloride Injection 0.9% from American Regent - Recall Due to Particulates - 3/21/2011
• Balanced Salt Solution by Cytosol Labs Recalled - 2/15/2006
• Balanced Solutions Compounding Pharmacy Recalls All Sterile Products Due to Concerns Regarding Sterility and Quality Control - 4/22/2013
• Baxter Buretrol Solution Set - Recall - 11/13/2012
• Becaplermin Gel (Regranex) and Risk of Cancer Death - Ongoing Safety Review - 6/10/2008
• Bedford Laboratories Recall: Polymyxin B and Vecuronium - 1/12/2012
• Belatacept (Nulojix): REMS Required Due to Post-Transplant Lymphoproliferative Disorder and Progressive Multifocal Leukoencephalopathy - 7/8/2011
• Benadryl Extra Strength Itch Stopping Gel - "For Skin Use Only" Added to Prominent Areas of the Product - 5/14/2010
• Bendamustine Hydrochloride (Treanda®) Recall – Particulate Matter in Vial - 1/30/2012
• Benzocaine Sprays, Gels and Liquids: Increased Risk of Methemoglobinemia - 4/8/2011
• Benzonatate (Tessalon) - Potential for Accidental Overdose by Children - 12/14/2010
• Benzoyl Peroxide 10% Topical Acne Gel - Product Recall - 11/18/2008
• Bevacizumab (Altuzan) – Counterfeit Product UPDATED - 2/6/2013
• Bevacizumab (Avastin®) – Counterfeit Product - 2/16/2012
• Bevacizumab (Avastin®) and Risk of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) and Nasal Septum Perforation - 9/27/2006
• Bevacizumab (Avastin®) and sunitinib (Sutent®) – combined use may increase risk of microangiopathic hemolytic anemia - 7/14/2008
• Bevacizumab (Avastin®) Repackaged Intravitreal Injections - Risk of Serious Infections - 9/1/2011
• Bevacizumab (Avastin) - FDA Removes Breast Cancer Indication - 11/21/2011
• Bevacizumab (Avastin) and Tracheoesophageal Fistula - 4/24/2007
• Bicillin C-R and Bicillin L-A (penicillin G benzathine suspension) – Inappropriate Use for Syphilis - 12/1/2004
• Bioidentical Hormone Replacement Therapy - Misleading Information - 1/11/2008
• Bismacine Injection (Chromacine) - Avoid Use for Lyme Disease - 7/25/2006
• Bisphosphonate-Induced (Pamidronate [Aredia] and zoledronate [Zometa]) Renal Dysfunction in Oncology Practice - 3/10/2005
• Bisphosphonates (alendronate [Fosamax, Fosamax plus D], etidronate [Didronel], ibandronate [Boniva], pamidronate [Aredia], risedronate [Actonel, Actonel and calcium], tiludronate [Skelid], zoledronic acid [Reclast, Zometa]) - Bone, Joint, and Musculoskeletal Pain Reminder - 1/8/2008
• Bisphosphonates of Safety Review of FDA Early Communication Regarding Atrial Fibrillation - 11/13/2008
• BIVIGAM Immune Globulin Intravenous (Human) Recall Due To Visible Particles - 04/09/2013
• Blood Glucose Test Strip Recall - OneTouch® SureStep® Test Strips - 3/2/2010
• Boceprevir (Victrelis) – Drug Interactions With Ritonavir-Boosted HIV Protease Inhibitors (Atazanavir, Darunavir, Lopinavir) – UPDATE - 4/27/2012
• Body Building Products Containing Unapproved Synthetic Steroids - FDA Issues Warning - 1/19/2010
• Bortezomib (Velcade) - Dose Adjustment in Hepatic Impairment - 1/27/2010
• Bosentan (Tracleer) 5/Cause Hepatotoxicity - 3/3/2006
• Botulinum Toxin (Botox) – Foreign Unapproved Products Sold by "Online Botox Pharmacy" - 5/7/2013
• Botulinum Toxin Types A (Botox, Botox Cosmetic, Dysport) and Botulinum Toxin Type B (Myobloc) - Safety Review Update and Names Changed to OnabotulinumtoxinA (Botox, Botox Cosmetic), AbobotulinumtoxinA (Dysport), and RimabotulinumtoxinB (Myobloc) - 8/4/2009
• Brazilian Diet Pills 5/Contain Chlordiazepoxide/Fluoxetine/or Stimulants - 1/19/2006
• Brentuximab Vedotin (Adcetris) – New Warnings About Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity - 1/17/2012
• Bupropion (Budeprion) XL 300 mg Tablets – Generic
  Not Bioequivalent to Wellbutrin XL 300 mg - 10/25/2012
• Bupropion (Zyban and generics) - Neuropsychiatric Events and Suicidality Warnings added to the Prescribing Information - 7/6/2009
• Butalbital / Acetaminophen / Caffeine Tablets and Hydrocodone / Acetaminophen Tablets from Qualitest - Recall Due To Potential Mislabeling - 6/27/2011
• Caffeine Citrate Powder/Purified - Recall - 5/22/2007
• Calcilo XD Infant Formula - Product Recall - 6/4/2008
• Calcitonin Salmon - FDA Advisory Panel Recommends Against the Use of Calcitonin Salmon for Postmenopausal Osteoporosis. - 3/12/2013
• Campral® (Acamprosate) Recall – Tablets Failed Dissolution Test - 3/22/2012
• Caraco Medications Seized by US Marshals Due to Ongoing Quality Problems UPDATED - 6/30/2009
• Carbamazepine (Tegretol) - Skin Reactions More Common in Patients with Human Leukocyte Antigen B*1502 Allele - 12/12/2007
• Cataplex and Pancreatrophin Dietary Supplements – Voluntary Recall Due To Potential Salmonella Contamination - 7/3/2012
• Cefepime (Maxipime®) - Ongoing Safety Reviewd - 6/18/2009
• Cefepime (Maxipime®) – Risk of Nonconvulsive Status Epilepticus - 6/27/2012
• Ceftriaxone Injection (Rocephin) - Interaction with Calcium Products and New Contraindication in Hyperbilirubinemic Neonates - 4/14/2009
• Celecoxib (Celebrex) cardiovascular risk - 12/21/2004
• Cetuximab (Erbitux) - Additional Monitoring for Electrolyte Abnormalities and Infusion Reactions - 9/15/2005
• Changes to CII prescribing - FAQ - 2/17/2005
• Changes to CII prescribing - Postdating no longer allowed - 3/23/2005
• Children’s Motrin (ibuprofen) chewable tablets may contain Tylenol (acetaminophen) – packaging error - 5/14/2004
• Children's Tylenol Meltaways 80 mg/Children's Tylenol SoftChews 80 mg/and Junior Tylenol Meltaways 160 mg - recalled due to confusing packaging and labeling - 6/6/2005
• Chlorhexidine Gluconate Skin Preparation Cloth - Recall - 7/2/2008
• Chondrolysis Associated with Continuously Infused Local Anesthetics [bupivacaine (Marcaine; Sensorcaine); chloroprocaine (Nesacaine); lidocaine (Xylocaine); mepivacaine (Carbocaine; Polocaine); procaine (Novocain); ropivacaine (Naropin)] - 11/17/2009
• Cidofovir Injection (Vistide) – 1 Lot Recalled Due to Particulate Matter - 02/20/2013
• Cinacalcet hydrochloride (Sensipar) – Pediatric clinical trials suspended following reported death - 03/05/2013
• Citalopram and Finasteride by Greenstone - Recalled due to Mislabeling - 3/29/2011
• Citalopram hydrobromide (Celexa) and Abnormal Heart Rhythms: New Labeling Changes - 3/29/2012
• Clarcon Hand Sanitizers and Skin Protectants Recall - 6/11/2009
• Clarithromycin (Biaxin/Biaxin XL)- study shows increased cardiovascular mortality - 12/13/2005
• Clevidipine Butyrate Injection (Cleviprex) - Recall - 3/19/2010
• Clindamycin Injection - APP Pharmaceuticals Recalls 11 Lots - 2/5/2010
• Clinical Specialties Compounding Pharmacy Recalls All Sterile Products - Potential for Lack of Sterility - UPDATED - 03/21/2013
• Clopidogrel Bisulfate (Plavix) - Potential Interactions with Omeprazole (Prilosec) and Esomeprazole (Nexium) - Ongoing Safety Review - 11/19/2010
• Clopidogrel Bisulfate (Plavix) -Box Warning on Poor Metabolizers - 3/15/2010
• Clozapine (Clozaril, generic) Labeling Changes - White Blood Cell Count Monitoring Changes - 1/13/2006
• Cochlear Implant Device Increases Risk of Pneumococcal Meningitis - Immunization Recommended - 10/11/2007
• Codeine – Risk of Rare, Possibly Fatal Adverse Events in Pediatric Patients after Tonsillectomy and/or Adenoidectomy - 8/20/2012
• Codeine use in Nursing Mothers with a Specific CYP2D6 Genotype may lead to Morphine Overdose in the Nursing Infant - 8/17/2007
• Colchicine Injection - Recall of Compounded Product - 5/3/2007
• Colistimethate (Coly-Mycin M®, generics) Inhalation Possibly Associated With Death - 7/2/2007
• Colistimethate Injection- Risk of Serious or Fatal Dosing Errors - 7/14/2011
• Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control - 5/23/2013
• Concentrated Sodium Chloride Injection 23.4% from American Regent - Recall Due to Particulates - 3/21/2011
• Conjugated Estrogen Products (Premarin, Prempro, and Premphase) - 2/16/2006
• Contact Lens Solutions: Fungal Eye Infections in Soft Contact Lens Wearers - 4/14/2006
• Conventional and Atypical Antipsychotics-Increased Risk of Death in Elderly Patients Taking Antipsychotics for Dementia-Related Psychosis - 6/16/2008
• Correct Use of Tiotropium Bromide (Spiriva) and Formoterol Fumarate (Foradil) Capsules - 3/4/2008
• Correction Notice - Typographical Errors in Pediatric Injectable Drugs, 8th Edition (The Teddy Bear Book) - 8/17/2009
• Corvalol - Unapproved Drug Contains Phenobarbital - 11/21/2008
• Cough and Cold Medications Update - Infant Deaths and Use in Children UPDATED - 10/10/2008
• Counterfeit Medications on the Internet - FDA Warning about Orlistat (Xenical) - 5/3/2007
• COX-2 Selective Inhibitors and NSAIDs - Patient Medication Guide Requirement - 6/16/2005
• Cranberry - Warfarin (Coumadin) Interaction has been Removed from Medication Guide - 12/20/2012
• Creon - Newly Approved Formulation Requires New Prescription - 7/6/2009
• Cyclopentolate and Tropicamide Administration Errors - 6/27/2008
• Cytarabine Injection Recall from Bedford Laboratories - 2/24/2012
• Dabigatran (Pradaxa®) - Important Storage and Handling Requirements - 11/9/2011
• Dabigatran Etexilate Mesylate (Pradaxa®) - Contraindicated in Patients with Mechanical Heart Valves - 12/24/2012
• Dabigatran etexilate mesylate (Pradaxa®) – Ongoing Safety Review
  of Post-Marketing Reports Related to Serious Bleeding Events UPDATE - 11/5/2012
• Daclizumab (Zenapax) – Updated Adverse Effect Information - 8/28/2003
• Dalfampridine (Ampyra®) – Increased Risk of Seizures - 7/26/2012
• Daptacel (DTaP) and Adacel (Tdap) Administration Errors - 2/2/2007
• Daptomycin (Cubicin) - MBT Contaminant When Stored in ReadyMED Elastomeric Pump - 4/10/2008
• Daptomycin (Cubicin) - Risk of Eosinophilic Pneumonia - 7/29/2010
• Darunavir (Prezista)- Hepatotoxicity Warnings - 3/14/2008
• Dasatinib (Sprycel) May Increase Risk of Pulmonary Arterial Hypertension - 10/12/2011
• Daytrana (Methylphenidate) Patch - Recall of Specific Lots by Shire Pharmaceuticals - 2/3/2010
• Daytrana™ (Methylphenidate Transdermal System) Recall - 9/7/2007
• DEA Numbers 5/Begin With Letter "F" - 10/16/2006
• Deferasirox (Exjade) - New Boxed Warning about Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events - 2/23/2010
• Deferasirox (Exjade) - Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events - 12/14/2007
• Denileukin diftitox (Ontak) 5/Cause Visual Loss - 3/17/2006
• Desipramine (Norpramin®) - New Warnings in Patients with a Family History of Cardiac Disorders - 12/3/2009
• Desmopressin - Risk of Hyponatremia and Seizures - 12/6/2007
• Dexamethasone Sodium Phosphate 4 mg/mL Injection from American Regent - Recall Due to Particulates - 3/21/2011
• Dexamethasone Sodium Phosphate Injection, 4 mg/mL, 30 mL Multiple Dose Vials Recalled - Particulates in Product - 12/28/2010
• Dexlansoprazole (Kapidex) - Brand Name Change, Confusion with Casodex and Kadian - 3/5/2010
• Dextroamphetamine (Dexedrine/Dexedrine Spansule) Labeling Changes/Including Sudden Death - 8/22/2006
• Dextroamphetamine sulfate 5 mg tablets by Ethex recall - 10/17/2008
• Dextroamphetamine/Amphetamine 20 mg Tablet Recall by Barr - 8/18/2009
• Dextromethorphan abuse associated with death - 5/25/2005
• Dialysate Concentrate Products Containing Acetate, Acetic Acid, Citrate – Dosing Errors - 05/25/2012
• Diazepam Rectal Gel (Diastat Acudial): Applicator Defect 5/Prevent Delivery of Complete Dose. - 3/31/2006
• Diclofenac Topical Gel 1% (Voltaren Gel) and Hepatic Toxicity - 12/7/2009
• Didanosine (Videx, Videx EC) and Non-Cirrhotic Portal Hypertension - 2/1/2010
• Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients - UPDATED - 5/8/2013
• Digestive 3-in-1 Health Liquid Dietary Supplement (Wellesse) - Voluntary Recall Due to Potential for Salmonella Contamination - 6/11/2012
• Digoxin Tablet Recall by Caraco - 5/13/2009
• Disposal of Prescription Medications in the Community - Federal Guidelines - 9/6/2011
• Dolasetron Safety Announcement - 12/17/2010
• Doxazosin 4 mg Extended Release Tablets (Cardura XL) Recalled by Pfizer for Irregular 8-hour Dissolution Result - 1/24/2012
• Dronedarone (Multaq®) – Two-fold Increased Risk of Death and Serious Adverse Events – Update - 09/20/2012
• Dronedarone (Multaq): Potential for Severe Liver Injury - 1/19/2011
• Droperidol (Inapsine) and risk of QT prolongation - 1/1/2002
• Drospirenone-Containing Birth Control Pills - Ongoing Safety Review for Increased Risk of Venous Thromboembolic Events - 6/1/2011
• Drospirenone-Containing Birth Control Pills – Labeling Changes for Possible Increased Risk of Venous Thromboembolic Events - 4/12/2012
• Drotrecogin alfa (Xigris) - Withdrawn From Worldwide Market - 10/25/2011
• Drotrecogin alfa (Xigris) may increase mortality in single organ dysfunction patients - 3/18/2005
• Drotrecogin alfa (Xigris) Not Effective in Pediatric Patients with Severe Sepsis - 4/29/2005
• Drotrecogin alfa [activated] (Xigris) - Ongoing Safety Review - 2/5/2009
• Dukal Corporation Recall of Benzalkonium Chloride Products Due to Potential Contamination - 8/2/2012
• Dulcolax Brand Products - not all formulations contain bisacodyl - 4/27/2004
• Duloxetine (Cymbalta®) 5/Exacerbate Hepatic Injury in Patients with Preexisting Liver Disease - 10/8/2009
• Duragesic Patch Recall UPDATE - 4/6/2004
• Ear Candles - Risk of Serious Injuries, Avoid Use - 2/23/2010
• Edetate Disodium - Sound-Alike Confusion with Edetate Calcium Disodium - 1/22/2008
• Efalizumab (Raptiva®) withdrawal - 4/13/2009
• Efalizumab (Raptiva) and Progressive Multifocal Leukoencephalopathy (Update) - 2/20/2009
• Efalizumab (Raptiva) associated with hemolytic anemia/thrombocytopenia/and serious infection - 7/20/2005
• Efavirenz (Sustiva) - Pregnancy Risk has Changed to Category D (positive evidence of fetal risk). - 6/13/2005
• Electronic Cigarette - A Potential Health Hazard - 7/28/2009
• Eli Lilly Discontinuing Humulin U Ultralente/Humulin L Lente/Regular Iletin II/and NPH Iletin II Insulin Products - 7/7/2005
• Eltrombopag (Promacta®) - Portal Venous System Thromboses in Patients with Chronic Liver Disease - 5/14/2010
• Enoxaparin (Lovenox) adjust dose for severe renal impairment - 8/17/2004
• Entacapone/carbidopa/levodopa (Stalevo): Ongoing Cardiovascular Safety Review - 8/23/2010
• Entacapone/carbidopa/levodopa (Stalevo): Ongoing Prostate Cancer Safety Review - 4/5/2010
• Entecavir (Baraclude) and Possible HIV Resistance - 8/20/2007
• Ephedra – FDA Plans to Ban Sale in Dietary Supplements - 12/30/2003
• Ephedrine alkaloids in dietary supplements illegal to market in US - 9/7/2006
• Epoetin Alfa (Epogen®/Procrit®) and Darbepoetin Alfa (Aranesph®) - Associated with Pure Red Cell Aplasia - 12/2/2005
• Epoetin alfa (Eprex) in the Treatment of Acute Ischemic Stroke - 9/30/2008
• Epoetin alfa, Darbepoetin alfa: New Risk Management Program - 3/25/2010
• Epoetin alfa/Darbepoetin alfa: Hemoglobin Target above 12 g/dL Increases Cardiovascular Risk - 11/20/2006
• Epogen® and Procrit® (Epoetin Alfa) - Recall - 9/29/2010
• Erectile Dysfunction Drugs and Vision Loss - 7/12/2005
• Ergotamine – FDA Halts Marketing of Unapproved Products - 3/5/2007
• Eribulin (Halaven) and Epirubicin (Ellence, generic) Name Confusion - 1/17/2012
• Erlotinib (Tarceva) and Hepatic Dysfunction - 9/24/2008
• Erlotinib (Tarceva) and New Safety Information - 5/8/2009
• Ertapenem Sodium (Invanz) Recall - 7/9/2007
• Erythropoiesis-Stimulating Agent (Darbepoetin alfa [Aranesp]) Increases Death in Non-Chemotherapy-Induced Anemia - 2/20/2007
• Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Epoetin alfa [Epogen, Procrit]) - Revised Black Box Warnings-Update - 3/14/2008
• Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Erythropoietin alfa [Epogen, Procrit]) - Proposed Changes in Product Labeling - 8/7/2009
• Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Erythropoietin alfa [Epogen, Procrit]) - Proposed Changes in Product Labeling for Kidney Disease - 6/27/2011
• Estradiol Transdermal Spray (Evamist): Unintended Exposure by Children and Pets - 7/30/2010
• Etanercept (Enbrel) Black Box Warning of Infection Risk - 5/2/2008
• Ethex Recalls Additional Products More Than 60 Drug Products-Update - 2/10/2009
• Etravirine (Intelence™): Severe Skin and Hypersensitivity Reactions - 9/3/2009
• Exenatide (Byetta®) - Altered Kidney Function Reported - 11/3/2009
• Exenatide (Byetta) and Pancreatitis - 8/20/2008
• Ezetimibe/Simvastatin versus Simvastatin Alone (ENHANCE) of Ongoing Data Review - 1/12/2009
• Ezogabine (Potiga™) - Linked to Blue Skin Discoloration and Retinal Abnormalities - 4/30/2013
• Famotidine and Lorazepam Administration Errors - 9/7/2006
• FD&C Blue No. 1 Toxicity - 10/3/2003
• FDA Bans the Manufacture of Unapproved Injectable Colchicine Products - 2/6/2008
• FDA Removes Unapproved Cough, Cold, and Allergy Products from U.S. Market - 3/2/2011
• FDA Warns Pharmacies Against Compounding Topical Anesthetic Creams and Other Products - 9/25/2009
• Fentanyl (Duragesic, generic) Boxed Warnings - 7/12/2005
• Fentanyl 25 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz) - 2/19/2008
• Fentanyl 25 mcg/hr Patch from Actavis - Recall - 10/22/2010
• Fentanyl 50 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz) - 1/2/2009
• Fentanyl Buccal Tablet (Fentora®) - Inappropriate Use Causes Death/Adverse Effects - 9/28/2007
• Fentanyl Transdermal Patch (Duragesic, generics) - Cautions About Safe and Appropriate Use - 12/24/2007
• Fentanyl Transdermal Patch (Duragesic, generics) – Cautions About Accidental Exposure - 4/20/2012
• Fentanyl Transdermal System Recall (Actavis, Abrika) - 3/4/2008
• Fentanyl Transmucosal Products (Abstral, Actiq, Fentora, Lazanda, Onsolis; generics) – New Class-Wide Risk Management Program - 3/13/2012
• Fingolimod (Gilenya) and Risk of Death – Ongoing Safety Review - 12/20/2011
• Flolan® (epoprostenol sodium): Use 0.22 or 0.2 Micron Filter to Remove Glass Particles - 4/10/2013
• Floranex (Lactobacillus) and Florinef (fludrocortisone) Name Confusion - 1/2/2007
• Fluconazole (Diflucan®): Chronic, High-Dose Therapy May be Associated with Birth Defects - 8/4/2011
• Fluoroquinolones and Tendinitis and Tendon Rupture - 7/9/2008
• Fluoroquinolones Boxed Warning: Myasthenia Gravis - 3/23/2011
• Fluvirin (Influenza Virus Vaccine) Recall - 12/27/2010
• Fosamprenavir (Lexiva) - Increased Risk of Myocardial Infarction and Dyslipidemia - 12/4/2009
• Fosphenytoin Sodium Injection from Hospira- Recall - 5/27/2010
• Franck’s Compounding - All Sterile Preparations - Do Not Use - 5/25/2012
• Fraudulent Avian Flu Therapies - Potentially harmful or 5/interfere with conventional treatments - 1/3/2006
• Fungal Meningitis Outbreak from Intrathecal Products
  at Compounding Pharmacy (UPDATED) - 11/02/2012
• Gabapentin 100 mg capsules (Neurontin) - Recall - 3/22/2005
• Gadolinium-Containing Contrast Agents (Omniscan®, OptiMARK®, Magnevist®, Eovist ®, Ablavar®, ProHance®, MultiHance®) and Serious Nephrogenic Fibroses - 9/10/2010
• Galactose, Maltose, and Xylose Products May Falsely Elevate Glucose Results - 8/24/2011
• Galantamine (Reminyl) - possible increased mortality in patients with mild cognitive impairment - 4/5/2005
• Galantamine brand name changed to Razadyne - 4/25/2005
• GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10%, 20g Recall – Labeling Error - 3/14/2012
• GammaGard Liquid Recall - 6/7/2010
• Gatifloxacin (Tequin) and Blood Glucose Abnormalities/Contraindicated in Diabetics - 2/17/2006
• Gefitinib (Iressa) - shows no survival benefit for non-small cell lung cancer/use discouraged. - 6/17/2005
• GemStar Infusion System Recall – Battery Leakage Causes System Damage - 5/3/2013
• Gemtuzumab Market Withdrawal - 6/23/2010
• GenTeal Gel and GenTeal GelDrops Artificial Tears Recall (Novartis Ophthalmics) - 11/23/2005
• Genzyme Products including alglucosidase alfa (Myozyme), algasidase beta (Fabrazyme), imiglucerase (Cerezyme), laronidase (Aldurazyme), and thyrotropin alfa (Thyrogen) - Possible Particulate Matter Contamination - 11/16/2009
• Golimumab (Simponi) Injection - Recall Due to Malfunctioning Autoinjector - 2/22/2011
• Gonadotropin-Releasing Hormone (GnRH) Agonists - Diabetes and Cardiovascular Risk with Goserelin (Zoladex), Histrelin (Vantas), Leuprolide (Eligard, Lupron, Viadur), Nafarelin (Synarel), and Triptorelin (Trelstar) - 10/21/2010
• GOPump Elastomeric Infusion PumpKit Recall - Displacement of Flow Restrictor Bead - 03/19/2013
• Gotu Kola (Centella asiatica) and Bladderwrack (Fucus vesiculosus) Dietary Supplement Recall – Potential Salmonella Contamination - 12/23/2011
• Green Valley Drugs Recalls All Sterile Compounded Products Due to Concerns Regarding Sterility and Quality Control - 4/12/2013
• Griseofulvin (Grifulvin V) Oral Suspension - Recall - 4/12/2007
• Guaifenesin Over-The-Counter Tablets - Recall Due to Mislabeling - 12/14/2010
• H1N1 Monovalent Vaccine Live 2009 (Intranasal) -Revised Expiration Dating - 1/15/2010
• Haloperidold Labeling Regarding Risk of Torsades de Pointes and QT Prolongation - 9/19/2007
• Heparin Container Labeling Change – Revised Labels to Prominently
  Display the Total Drug Strength in Container - 12/7/2012
• Heparin - Voluntary Recall of Baxter Heparin Vials, B. Braun Heparin Large Volume Infusion Bags, and Covidien (Kendall) Heparin Flush Prefilled Syringes - 6/18/2008
• Heparin Administration Errors - Use of Incorrect Concentrations - 2/12/2007
• Heparin -Induced Thrombocytopenia - Delayed-Onset Warning - 12/12/2006
• Heparin Lock Flush Pre-filled Syringes and Normal Saline Pre-filled Flush Syringes Recalled by AM2 PAT, Inc. - 1/23/2008
• Heparin Sodium - Voluntary Recall of 7 lots of B. Braun Heparin Products - 11/2/2010
• Heparin: Change in Reference Standard- New Universal Standardization in Heparin Potency - 4/8/2010
• HMG-CoA-reductase inhibitors do not increase incidence of amyotrophic lateral sclerosis (AML) - 9/30/2008
• hormone replacement therapy update - 4/16/2004
• Hospira Carpuject Pre-filled Cartridges - Potential for Overfill - Visually Examine Prior to Administering - 05/23/2012
• Hospira Hydromorphone Injection Recall Due to Potential Overfill - 08/17/2012
• Hospira Recall of Injectable Carboplatin Due
  to Presence of Drug Crystals - 12/17/2012
• Hospira Recall of Injectable Carboplatin, Cytarabine, Paclitaxel, and Methotrexate Due to Presence of Particulate Matter - 7/16/2012
• Hospira Recall of Lactated Ringer’s and 5% Dextrose Injection Expands to 2 Lots – Update - 01/29/2013
• Hospira Recall - Potassium 20 mEq in 5% Dextrose/ 0.45% Sodium Chloride - 12/9/2008
• Hospira Recall of Sodium Chloride Injection 0.9%, 1,000 mL Flexible Containers - 4/2/2013
• Hospira recall of Sodium Chloride 0.9% and Lidocaine 0.4% in Dextrose 5% - 1/25/2012
• Hospira Recalls One Lot of Sodium Chloride Injection 0.9%, 100 mL Flexible Containers - 04/26/2013
• Human Growth Hormone, Recombinant (somatropin) - FDA Review for Increased Risk of Death - 12/23/2010
• Human Papillomavirus Recombinant Quadrivalent Vaccine, Types 6, 11, 16, 18 (Gardasil®) -Safety Update - 7/25/2008
• Human rabies vaccine (Imovax - Aventis Pasteur) - 4/6/2004
• Hydralazine HCl 20mg/mL Injection - Recall - 8/18/2006
• Hydrocodone 10 mg/Acetaminophen 500 mg Tablets - Watson Recalls 2 Lots Due to Possibility of Oversized Tablets - 9/25/2012
• Hydrocodone Antitussives - FDA Halts Marketing of Unapproved Products - 9/28/2007
• Hydrocodone Long-Acting Antitussives (Tussionex) - Safe Use - 4/24/2008
• Hydrocodone with Acetaminophen Tablets and Phenobarbital Tablets (Qualitest Pharmaceuticals) - Recall Due to Incorrect Labeling - 2/8/2011
• Hydromorphone 2 mg Tablet Recall by Ethex - 12/24/2008
• Hydromorphone Extended Release (Palladone) withdrawn for safety reasons - 7/14/2005
• Hydromorphone HCl Injection, 1 mg/1 mL Carpuject – Voluntary Recall Due to Potential for Excess Fill Volume - 5/15/2012
• Hydroxycut Consumer Warning and Product Recall - 5/4/2009
• Hydroxyurea (Droxia, Hydrea, generic) Associated Cutaneous Vasculitic Toxicities - 1/26/2006
• Hyland's Teething Tablets Recalled - Potential Risk of Harm to Children - 10/25/2010
• Hylenex Injection from Baxter Healthcare - Recall - 5/27/2010
• Hyperactivity Medications: Patient Medication Guide Required due to Cardiovascular and Psychiatric Adverse Effects - 2/23/2007
• Ibritumomab tiuxetan (Zevalin) and Rituximab (Rituxan) - Potentially-fatal Skin and Mucus Membrane Reactions - 10/8/2009
• Ibuprofen and Aspirin Drug Interaction - 9/14/2006
• Ibuprofen topical OTC formulations marketed unlawfully - Warning letters issued by the FDA - 8/26/2009
• Icy Hot Heat Therapy Products - Recall - 3/11/2008
• iFlora® Kids Multi-Probiotic® And iFlora™ 4-Kids Powder Dietary Supplements- Voluntary Recall Due to Potential for Salmonella Contamination Updated - 7/11/2012
• I-FLOW ON-Q Pump with ONDEMAND Bolus Button Recall – Continuous Infusion Risk - 09/06/2012
• Imatinib Mesylate (Gleevec®) - Cardiac Events - 10/19/2006
• Immune Globulin Intravenous (IGIV), Subcutaneous (SCIG), or Intramuscular
  – Risk of Thrombosis or Hemolysis - 11/16/2012
• Immune Globulin (GamaSTAN S/D™) - Uncalibrated Syringes - 3/6/2008
• Immune Globulin Intravenous (IGIV) May be Associated with Thrombotic Events - 5/20/2002
• Immunosuppressant Drugs - Labeling Changes Warning of Increased Risk of Opportunistic Infections - 7/16/2009
• Incretin Memetic Drugs—Possible Increased Risk of Pancreatitis and Precancerous Pancreatic Cells - 03/20/2013
• Indomethacin for Injection by Bedford - Voluntary Recall of a Single Lot - 6/16/2011
• Infant Formula by Gentlease Recalled - 2/24/2006
• Infant Formula with Iron Recall - Abbott Similac Special Care 24 Cal/fl. oz. Ready-to-Feed Premature - 5/30/2007
• Infants' Mylicon Gas Relief Dye Free Drops Recall - 11/13/2008
• Infliximab (Remicade) and CNS manifestations - 8/25/2004
• Infliximab (Remicade) associated with hepatotoxicity - 12/22/2004
• Influenza Virus Vaccine (Afluria®) - Risk of Febrile Events - 8/2/2010
• Inhaled Insulin (Exubera) and Lung Cancer - 4/10/2008
• Insulin Detemir (Levemir) - Stolen Vials Resurface, Product Potentially Defective - 8/26/2009
• Insulin Glargine (Lantus) - Risk of Cancer - 7/1/2009
• Insulin Pens and Cartridges - Risk of Blood-Borne Disease Transmission with Shared Use - 3/20/2009
• Insulin Syringe (ReliOn) Recall - 11/7/2008
• Interferon Alfa-2b (Intron A) Injection Pens - Recall of Several Lots by Schering-Plough - 11/11/2009
• Interferon beta-1a (Avonex, Rebif) – Reports of serious hepatic injury - 3/17/2005
• Interferon beta-1b (Betaseron) may cause hepatotoxicity - 4/25/2005
• Interferon Gamma-1b (Actimmune) - Early Termination of Trial for Idiopathic Pulmonary Fibrosis - 3/9/2007
• Intestinomicina Safety Alert – Product Contains Chloramphenicol and Other Antibacterial Agents - 9/18/2012
• Intravenous Ciprofloxacin, Metronidazole, and Ondansetron Injection Made by Claris Lifesciences - Recall - 6/1/2010
• Iopamidol Injection (Isovue FLS2) Prefilled Power Injector
  Syringes Recalled by Bracco Diagnostics - 12/03/2012
• Iopromide 370 mg/mL Injection (Ultravist) Recall - 7/25/2006
• Ipilimumab (Yervoy) and Serious Immune Mediated Adverse Reactions - 4/6/2011
• Irinotecan Hydrochloride Injection - Recall Due to Fungal Contamination - 3/28/2011
• Iron dextran injection (Dexferrum) - Black Box Warning for Potentially Fatal Anaphylactic Reaction - 10/20/2009
• Isotretinoin (Accutane®, generic): New risk management program - iPLEDGE - 8/17/2005
• Isotretinoin (Accutane, generic) - New Informational FDA web site - 3/29/2007
• Kaopectate and Generic Kaolin-Pectin Products - Reformulation - 8/2/2006
• Ketamine HCl (Ketalar) 10mg/mL Injection - Recall - 12/14/2006
• Ketorolac Tromethamine Injection - Voluntary Recall - 10/22/2009
• Koff and Kold and Kold Sore Products from Wholistic Herbs Inc Recalled – Non-Sterile Products - 2/13/2012
• KV Pharmaceutical Tablet Shipment Suspension - 12/24/2008
• Lamisil (Terbinafine) and Lamictal (Lamotrigine) Name Confusion - 8/7/2006
• Lamivudine (Epivir), Abacavir (Ziagen), and Tenofovir (Viread): Early Virologic Non-Response with Concomitant Use - 7/31/2003
• Lamotrigine (Lamictal) and Aseptic Meningitis - 8/13/2010
• Lamotrigine (Lamictal) During Pregnancy 5/Increase Risk of Cleft Lip or Cleft Palate - 10/3/2006
• Lansoprazole Delayed-Release Orally Disintegrating Tablets from Teva - Withdrawn for Clogging Oral Syringes and Feeding Tubes - 4/15/2011
• Lantus (insulin glargine [rDNA origin] injection recall Lot 40D024/Lot 40D025/Lot 40D027) - 8/19/2004
• Leflunomide (Arava) and Risk of Severe Liver Injury - 7/14/2010
• Lenalidomide (Revlimid): Ongoing Safety Review for Increased Malignancy Risk - 4/11/2011
• Leucovorin Calcium Injection from Bedford – Voluntary Recall Due To Particulate Matter - 7/6/2012
• Levomethadyl hydrochloride acetate (Orlaam) Discontinued - 9/10/2003
• Levonorgestrel and Ethinyl Estradiol Tablets (Introvale®) – Voluntary Recall Due to Possible Flaw in Packaging - 6/7/2012
• Levoxyl labeling changes – risk of choking, gagging, and dysphagia - 10/6/2004
• LifeScan Recalls all OneTouch® Verio®IQ Blood Glucose Meters due to Defective Reporting of Extremely High Blood Glucose Levels - 04/24/2013
• Linezolid (Zyvox®) - Increased Mortality Following Treatment of Intravascular Catheter-Related Infections - d 3/19/2007
• Linezolid (Zyvox) - Intravenous injection transitioning to Freeflex® IV bag - 2/22/2011
• Liposyn II and Liposyn III (Hospira) - Recall of Additional Lots Due to Presence of Particulate Matter - 6/11/2010
• Liraglutide [rDNA origin] (Victoza)- Risk of Acute Pancreatitis and Thyroid C-cell Tumors - 6/14/2011
• Live Oral Pentavalent Rotavirus Vaccine (RotaTeq) - Post-Marketing Reports of Intussusception - 2/20/2007
• Live Oral Pentavalent Rotavirus Vaccine (RotaTeq) - Reports of Kawasaki Disease - 6/19/2007
• Long-Acting Beta 2-Agonists Can Increase Severe Asthma Episodes - 11/18/2005
• Long-Acting Beta-2 agonists (Formoterol [Foradil Aerolizer], Formoterol/Fluticasone [Symbicort], Salmeterol [Serevent Diskus], Salmeterol/Fluticasone [Advair Diskus, Advair HFA]) - New Requirements for Use in Asthma - 2/23/2010
• Lopinavir/Ritonavir (Kaletra) Oral Solution - Warning Added to Label: Risk of Serious Adverse Events in Premature Babies - 3/9/2011
• Lopinavir/Ritonavir Oral Solution (Kaletra) - Potential Risk of Overdose in Children - 8/15/2007
• Lovastatin (Mevacor) Labeling Changes: New Drug Interactions & Dose Restrictions - 3/1/2012
• Maalox Brand Products and Potential for Medication Errors - 2/18/2010
• Magnesium Sulfate and Potassium Phosphate - Potential for Error - 8/6/2009
• MBI Ordered to Cease Manufacturing and Distributing Products - 12/2/2005
• McNeil Consumer Healthcare Recall of OTC Products Due to Possible Chemical Contamination - 10/20/2010
• Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) - Ongoing Safety Review - 3/4/2008
• Medicaid Tamper-Resistant Requirement - Delayed 6 Months - 9/28/2007
• Med Prep Consulting Voluntarily Recalls All Compounded Injectable Products – Risk of Contamination - 03/19/2013
• Medroxyprogesterone Acetate & Estradiol Cypionate Injectable Suspension (Lunelle™) – Product Recall - 10/14/2002
• Medroxyprogesterone acetate injection (Depo-Provera® Contraceptive Injection) reduces bone mineral density - 11/22/2004
• Mefloquine (Lariam®) contraindicated in patients with a history of psychiatric disorders - 10/4/2002
• Meningococcal Conjugate Vaccine (Menactra) Associated with Guillain Barré Syndrome - 10/24/2006
• meningococcal polysaccharide vaccine - 10/28/2002
• Merck Recalls Celestone® (Betamethasone) Oral Solution Due to Dosing Variability - 1/30/2012
• METABOSLIM Dietary Supplement Contains Undeclared Sibutramine - 8/22/2007
• Methadone Hydrochloride (Dolophine, generics) - Cardiac and Respiratory Deaths - 11/28/2006
• Methotrexate Injection – New Safety Labeling Changes - 12/28/2011
• Methotrexate Injection From Bedford Recalled Due to Ethylene Glycol Content - 12/15/2005
• Methotrexate Injection Recalled - Potential Glass Particulates In Vials - 11/1/2010
• Methylene blue and Psychiatric Medication interactions - 10/21/2011
• Methylphenidate hydrochloride 2.5 mg, 5 mg, and 10 mg Chewable Tablets (Methylin CT) – Recall Update - 2/10/2005
• Metoclopramide (Reglan, generic) - Black Box Warning for Tardive Dyskinesia - 2/27/2009
• Metronidazole 250 mg Tablets by Teva - One Lot Recalled Due to Underweight Tablets - 1/7/2011
• Metronidazole Injection from Sagent Pharmaceuticals - Recall - 5/18/2010
• Micro-bubble Perflutren Contrast Agents (Definity and Optison) Associated with Deaths and Serious Cardiopulmonary Reactions - 7/17/2008
• Midazolam Hydrochloride and Furosemide - Potential for Error - 8/11/2009
• Midodrine (ProAmatine, generic) Proposed Market Withdrawal - 9/10/2010
• Mifepristone (Mifeprex/RU-486) associated with serious infection and bleeding - 3/20/2006
• Minocycline (Solodyn) - Two lots recalled due to product mix-up - 5/21/2008
• Miracle Mineral Solution (MMS) - Produces Harmful Chlorine Dioxide when Mixed as Directed with Citrus Juice - 8/2/2010
• Mislabeled Internet Medications - Dangerous Ingredients - 2/21/2007
• Mitomycin Solution for Ophthalmic Use (Mitosol) Recalled by Mobius – May Not Be Sterile - 1/11/2013
• Mitoxantrone (Novantrone) - Cardiac Monitoring - 7/30/2008
• Mitoxantrone (Novantrone) - Cardiotoxicity and Secondary Acute Myelogenous Leukemia (AML) in Patients with Multiple Sclerosis - 5/25/2005
• Modafanil (Provigil) - Rash and Psychiatric Warnings - 10/25/2007
• Mommy's Bliss Nipple Cream - Harmful Ingredients for Nursing Babies - 5/30/2008
• Montelukast (Singulair) and Risk of Behavior Changes, Mood Changes, or Suicidality - Ongoing Safety Review - 6/12/2009
• Morphine Extended Release (Avinza) – Alcohol may cause dose-dumping - 11/4/2005
• Morphine Sulfate 20 mg/mL Concentrated Oral Solution (Roxanol) - 11/2/2009
• Morphine Sulfate Injection, 4 mg/1 mL Carpuject – Voluntary Recall Due to Potential for Excess Fill Volume - 4/18/2012
• Morphine Sulfate Oral Solution - Reports of Accidental Overdose Due to Medication Use Error - 1/12/2011
• Morphine Sulfate/Naltrexone HCl (Embeda®) - Voluntary Recall Due to Stability Concerns - 3/18/2011
• Motrin® IB (Ibuprofen) Caplets and Tablets - Recall Due To Dissolution Problems - 12/23/2011
• Multi-Mex Dietary Supplements - Recall Due To Misleading Names and Packaging - 5/12/2011
• Mycophenolate Mofetil (CellCept®) associated with Pure Red Cell Aplasia (PRCA) - 8/17/2009
• Mycophenolate Mofetil (CellCept) and Mycophenolate Acid (Myfortic) and risk of Progressive Multifocal Leukoencephalopathy - Ongoing Safety Reviewd - 6/30/2008
• Mycophenolate Mofetil (Cellcept) and Mycophenolic Acid (Myfortic) and Birth Defect Risk - 5/16/2008
• Mycophenolate Mofetil (Cellcept) Plus Sirolimus (Rapamune) - Increased Acute Rejection In Cardiac Transplant Patients - 2/26/2007
• Mycophenolate products (Cellcept - mycophenolate mofetil, Myfortic - mycophenolic acid) - Medication Guide Now Required - 3/24/2009
• Mycophenolate Products (Cellcept, Myfortic) - Pregnancy Risk Category Updated - 11/27/2007
• Mycophenolic Acid (Myfortic®) - warning for risk of Pure Red Cell Aplasia (PRCA) - 9/9/2009
• Nalbuphine (Nubain) - Use During Labor and Delivery - 1/10/2006
• Naltrexone Extended-Release Injectable Suspension (Vivitrol) - Injection Site Reactions and New Medication Guide Requirement UPDATE - 5/5/2010
• Name confusion with Zyprexa (olanzapine) and Zyrtec (cetirizine HCl) may lead to medication errors - 2/10/2005
• Naproxen (Aleve/Anaprox/Naprelan/Naprosyn) cardiovascular risk - 12/21/2004
• Natalizumab (Tysabri) - Reports of Liver Injury after Natalizumab Use - 2/29/2008
• Natalizumab (Tysabri) - Resumed Marketing With a Special Restricted Distribution Program - 6/6/2006
• Natalizumab (Tysabri) Monotherapy and Progressive Multifocal Leukoencephalopathy - 1/23/2012
• National Provider Identifier (NPI) - Personal Information Alert - 8/27/2007
• Nature Relief Instant Wart and Mole Remover - Recall Due to Risk of Serious Skin Burns - 6/29/2011
• NC Solution, and other Products by General Therapeutics Corp. Seized - 11/2/2007
• Nefazodone 50 mg/100 mg/150 mg/200 mg/and 250 mg Tablets Recall (Ivax Pharmaceuticals) - 3/31/2005
• Nelfinavir Mesylate (Viracept) - New Impurity Specifications - 9/14/2007
• NeoProfen (ibuprofen lysine) injection (Lundbeck) - Recall of Two Lots Due to Presence of Particulate Matter - 8/3/2010
• Nesiritide (Natrecor) may adversely effect short-term survival and kidney function in patients with decompensated heart failure - 5/20/2005
• Neuraminidase Inhibitors, Oseltamivir Phosphate (Tamiflu) and Zanamivir (Relenza), Associated with Neuropsychiatric Events - 4/3/2008
• Nevarapine (Viramune) Associated with Potentially-Fatal Hepatotoxicity - 2/2/2004
• Nevirapine (Viramune®) - Risk factors for liver toxicity - 1/20/2005
• New Guidelines For Appropriate Nesiritide (Natrecor) Use - 7/20/2005
• New Infant Acetaminophen Concentration Available – Use Caution to Avoid Dosing Errors - 12/23/2011
• New Labeling Changes for Statin Drug Class - 3/1/2012
• New Labeling Changes for Statin Drug Class and HIV and HCV C Medications – Drug Interactions - 3/1/2012
• Nifedipine (Nifediac™ CC) Extended Release Tablets- Recall - 7/9/2008
• Nimodipine capsules warning: Do not give parenterally - 8/2/2010
• Nimodipine (Nimotop ®) Manufacturer Recall: Crystals in Capsule Fill Solution - 9/5/2012
• Non-Acetone Nail Polish Remover (Personal Care Products) - Recall, Potential for Chemical Burns - 4/29/2009
• Nora Apothecary & Alternative Therapies Recalls All Sterile Compounded Products Due to Concern Regarding Sterility and Quality Control - 04/24/2013
• Norelgestromin/ethinyl estradiol patch (Ortho Evra) May Increase Blood Clot Risk - 9/21/2006
• norethindrone and ethinyl estradiol tablets (Nortrel) - Jul-03
• Norgestimate & Ethinyl Estradiol Tablets Recall – Potential for Incorrect Sequence of Tablets - 2/27/2012
• Norgestrel / Ethinyl Estradiol Tablets (Lo/Ovral®-28, generic) Recall – Potential for Wrong Tablet Count or Sequence - 2/1/2012
• Novartis Recall of Several Over-the-Counter Medications - 1/10/2012
• NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection/[rDNA origin]) NovoLog (insulin aspart [rDNA origin] injection) - Change in Packaging to Help Prevent Dispensing Errors - 9/16/2005
• NuCel Labs “Eye Drops” and “Eye/Ear Wash” Recalled - 2/1/2008
• NuVision Pharmacy Recalls Lyophilized HcG and Sermorelin/GHRH6 Injectables Due to Concerns Regarding Sterility and Quality Control - 04/18/2013
• Nzu Dietary Supplements for Morning Sickness Contain Arsenic and Lead - 1/4/2010
• Octagam (Immune Globulin Intravenous 5% Liquid) Market Withdrawal - 9/24/2010
• Olanzapine (Zyprexa, Zyprexa Zydis) - Use with Caution in Adolescents - 2/1/2010
• Olmesartan (Benicar®) and Increased Cardiovascular Events Ongoing Safety Review - 6/14/2010
• Omalizumab (Xolair®) - Ongoing Safety Review Update - 7/16/2009
• Omalizumab (Xolair) - Reports of Delayed Anaphylaxis - 7/3/2007
• Omega-3-acid Ethyl Esters Brand Name Changed from Omacor to Lovaza - 8/16/2007
• Omeprazole (Prilosec/Zegerid/generic) and Esomeprazole (Nexium) - Possible Association with Cardiac Events - 12/12/2007
• Ondansetron (Zofran, generic) and Risk of Abnormal Heart Rhythms or QT prolongation – Updated - 12/06/2012
• OneTouch® Blood Glucose Test Strips - Counterfeit Alert - 10/17/2006
• Opiate and Opiate-Containing Mix-ups with Endo Medications - 1/9/2012
• Opioid Long Acting and Extended Release Presentations – New Class-Wide Risk Management Program - 7/10/2012
• Oral Bisphosphonates and Hip Fracture - Alendronate (Fosamax), Ibandronate (Boniva), Risedronate (Actonel), Zoledronic Acid (Reclast) (Update) - 10/14/2010
• Oral Colchicine (Colcrys) - Severe Drug Interactions with Strong CYP3A4 and P-glycoprotein Inhibitors - 8/3/2009
• Oral Osteoporosis Drugs (Bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer - 7/22/2011
• Oral Sodium Phosphate Products for Bowel Cleansing - Renal Adverse Effects - 12/12/2008
• Orlistat (Alli) - - Counterfeit Capsules - 1/26/2010
• Orlistat (Xenical and Alli) and Severe Liver Injury - 5/26/2010
• Ortho Evra (norelgestromin/ethinyl estradiol): higher estrogen exposure than oral contraceptives - 11/15/2005
• Ortho Evra® (norelgestromin/ethinyl estradiol) Labeling Update - 1/23/2008
• Oseltamavir (Tamiflu) Counterfeit Products Sold on Internet - 6/18/2010
• Oseltamivir (Tamiflu®) Oral Suspension- Labeling Change to Reflect New Concentration (6 mg/mL) - 7/13/2011
• Oseltamivir (Tamiflu) Oral Suspension-Potential for Dosing Errors - 9/29/2009
• OTC Eye Drops and Nasal Sprays - Serious Adverse Events from Accidental Ingestion by Children - 10/26/2012
• Over-the-Counter (OTC) Chelated Products - FDA Warns Against Use - 10/18/2010
• Over-The-Counter Camolyn Eye Drops And Fisiolin Nasal Drops - Recall For Possible Sterility Problems - 4/8/2010
• Over-The-Counter Infants' and Children's Products - Voluntary Recall by McNeil Consumer Healthcare - 5/3/2010
• Oxcarbazepine (Trileptal) may cause serious skin and multiorgan hypersensitivity reactions - 4/25/2005
• Oxycodone 10 mg / Acetaminophen 325 mg Tablets (Endocet 10 mg / 325 mg) from Endo Recalled - Bottles May Contain Different Tablet Strengths - 6/27/2011
• Oxycodone Extended-Release Tablets From Endo, Dava, and Watson - Discontinued - 7/5/2007
• OxyContin (oxycodone extended-release) manufacturer pleads guilty to misbranding and misrepresenting product - 5/11/2007
• Oxymetazoline (Nostrilla®) Nasal Decongestant - Recall Due to Possible Bacterial Contamination - 10/24/2011
• Pai You Guo Dietary Supplement Contains Undeclared Sibutramine and Phenolphthalein - 11/13/2009
• Paliperidone palmitate (Invega Sustenna) - Recall Due to Cracks in Syringes - 2/17/2011
• Pallimed Solutions Recalls All Sterile Compounded Products Due To Visible Particulates - 3/28/2013

• Pamidronate and Zoledronic acid - reports of jaw osteonecrosis - 5/20/2005
• Pancreatic Enzyme Products - New Products and Changes in Product Availability - 05/22/2012
  • Information for University of Utah Healthcare Employees
  • Information for the Public
• Pantoprazole (Protonix) I.V. glass vial breakage - 9/27/2004
• Paroxetine (Paxil®/Paxil CR®) Labeling Changes - Suicidality in Adults - 10/8/2009
• Paxil and Paxil CRd Pregnancy Precautions - 12/8/2005
• PediaCare Children's Products from Blacksmith Brands - Recall - 6/1/2010
• Pegaptanib Sodium Injection (Macugen): Labeling Changes Due to Reports of Anaphylaxis and Angioedema - 4/7/2006
• Peginesatide Injection (Omontys®) - All Lots Recalled Due to Hypersensitivity Reactions - 03/04/2013
• Pemoline (Cylert, generic) Products Withdrawn from Market due to Risk of Liver Toxicity - 10/28/2005
• Pentrexyl Forte Natural Supplements - Recall Due To Misleading Packaging - 5/24/2011
• Peramivir Injection - Emergency Use Authorization for H1N1 Influenza - 12/1/2009
• Pergolide Mesylate (Permax) Associated with Cardiac Valve Disorders - 2/25/2003
• Pergolide Products Withdrawn From Market Due to Heart Valve Damage - 3/30/2007
• PharmaFab to Stop Manufacturing Unapproved Drugs - 4/27/2007
• Phenylephrine Injection Recall from American Regent - 2/24/2012
• Phenytoin and Fosphenytoin - Skin Reactions More Common in Patients with the Human Leukocyte Antigen Allele, HLA*B 1502. - 11/25/2008
• Phosphocol P 32 - Increased Risk of Leukemia and Radiation Injury - 9/19/2008
• Pioglitazone (Actos): Ongoing Safety Review for Increased Risk of Bladder Cancer - 9/20/2010
• Pioglitazone (Actos/Actoplus Met/Duetact) and Rosiglitazone (Avandia/Avandamet/Avandaryl) Increased Fracture Risk - 3/9/2007
• Piperacillin/Tazobactam for Injection 40.5 Grams Recall: Possible Precipitation or Crystallization of Some Lots - 4/30/2013
• Potassium Iodide - Recommendations for Use After Radiation Exposure - 3/16/2011
• Potassium Phosphates Injection - Recall Due to Particulates - 2/7/2011
• Potassium Phosphates Injection - Recall Due to Particulates, Filter Non-Recalled Lots - 4/22/2011
• Potential Cancer Risk With Topical Pimecrolimus (Elidel) and Tacrolimus (Protopic) - Updated - 1/24/2006
• Povidone Iodine Prep Pads - Recall Due to Possible Microbial Contamination - 3/22/2011
• Povidone Iodine Products - Recall Due to Inadequate Microbial Testing - 8/29/2011
• Pramipexole (Mirapex®) – Ongoing Safety Analysis and Possible Increased Risk of Heart Failure - 9/21/2012
• Pre-filled Glass Syringes - Compatibility Problems with Needless Intravenous Access Systems - 5/6/2011
• Prevnar (Pneumococcal 7-valent Conjugate) Vaccine Recall - 7/20/2009
• Promethazine (Phenergan) injection classified as vesicant - 4/25/2005
• Promethazine (Phenergan, generic) and Fatal Respiratory Depression In Children Under 2 Years of Age – Use Contraindicated - 2/18/2005
• Promethazine Hydrochloride Injection - Black Box Warning for Severe Tissue Injury - 9/17/2009
• Propafenone HCL 225 mg tablet recall by Watson - 3/25/2009
• Propofol (Diprivan/generics) - Adverse Events Resembling Bacterial Sepsis - 6/19/2007
• Propofol (Hospira) - Recall of Additional Lots Due to Presence of Particulate Matter - 6/11/2010
• Propofol (Hospira) - Recall of Three Lots Due to Glass Vial Defect - 8/21/2012
• Propofol (Teva) - Recall of Two Lots Due to Presence of Endotoxin - 7/17/2009
• Propoxyphene Products (Darvon, Darvocet) - Withdrawn From the Market - 11/22/2010
• Propylthiouracil (PTU) - Risk of Hepatotoxicity - 4/26/2010
• Protandim® Dietary Supplement Caplets Recalled by
  LifeVantage - May Contain Metal Fragments - 12/10/2012
• Proton Pump Inhibitors (PPI) and Risk of Fracture: Class Labeling Change - 5/26/2010
• Proton Pump Inhibitors (PPIs) – May Increase Risk of Clostridium Difficile-Associated Diarrhea (CDAD) - 2/9/2012
• Proton Pump Inhibitors-Risk for Low Magnesium Levels with Prolonged Use - 3/2/2011
• Qualitest Pharmaceuticals Oral Contraceptives - Recall Due to Packaging Error - 9/19/2011
• Qualitest Recall of Oversized Hydrocodone 10 mg/Acetaminophen 500 mg Tablets
  Expands to More Than 100 Lots and 3 Lots Repackaged by Mylan – UPDATE - 12/24/2012
• Que She Dietary Supplement Contains Undeclared Sibutramine, Fenfluramine, Propranolol, and Ephedrine - 7/9/2010
• Quetiapine (Seroquel) 25 mg tablet recall Lot 3446J - 5/5/2004
• Quinine (Qualaquin) and Serious Hematologic Reactions - 7/9/2010
• Quinine Sulfate - FDA Orders Halt of the Sale of Unapproved Products - 12/13/2006
• Quinolones and Blood Glucose Abnormalities (Hypoglycemia/Hyperglycemia) - 2/17/2006
• Rabies Immune Globulin (HyperRAB S/D) - Uncalibrated Syringes - 2/25/2008
• Ranibizumab (Lucentis®) 0.5 mg Increases Stroke Risk - 2/2/2007
• Recall of Dietary Supplement Products Containing Aromatase Inhibitors - 9/20/2010
• Recall of Goldline Brand Extra-Strength Acetaminophen 500 mg (Genapap/Genebs) - 5/5/2006
• Recall of Perrigo Infant Drops containing Acetaminophen/Dextromethorphan/or Pseudoephedrine - 8/4/2005
• Recombinant Factor VIIa (NovoSeven) - Increased Risk of Arterial Thromboembolic Events - 10/8/2009
• Red Yeast Rice Supplements 5/Contain Lovastatin - 8/14/2007
• Remifentanil Hydrochloride (Ultiva) - Typographical Error in the Handbook on Injectable Drugs - 11/6/2009
• Reumofan Plus Tablets Contain Diclofenac Sodium, Methocarbamol, and Dexamethasone - UPDATED - 8/22/2012
• Rho(D) Immune Globulin Intravenous (Human) (WinRho SDF) Black Box Warning of Intravascular Hemolysis - 3/11/2010
• Rho(D) Immune Globulin Intravenous (WinRho) - Hematologic Safety Reports - 10/8/2012
• Rifampin Injection, Pfizer Issues Warning for Discolored Product - 03/22/2013
• Risk of Invasive Staphylococcus aureus Infections with Improper use of Single-Dose Vials - 7/13/2012
• Risperidone (Risperdal®) and Risk of Cerebrovascular Events - 4/2003
• Risperidone (Risperdal) and Ropinirole (Requip) - Medication Errors Due to Name Confusion - 6/16/2011
• Risperidone and Risperdal® - Recall Due To Unusual Odor - 6/21/2011
• Rituximab (Rituxan®) and Progressive Multifocal Leukoencephalopathy (PML) - 10/26/2009
• Rituximab (Rituxan) and Hepatitis - 10/11/2004
• Rofecoxib (Vioxx®) withdrawn due to cardiovascular risk - 9/30/2004
• Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews, and Rolaids Multi-Symptom plus Anti-Gas Softchews Recalled - Foreign Materials in Product - 12/14/2010
• Romiplastim and Eltrombopag Risk Evaluation and Mitigation Strategy (REMS) Program - 12/9/2011
• Rosiglitazone (Avandia) - Association with Ischemic Cardiovascular Events - 2/4/2011
• Rosiglitazone (Avandia) and Pioglitazone (Actos) - Stronger Warnings about Heart Failure - 8/15/2007
• Rosiglitazone (Avandia, Avandamet, Avandaryl) - New Onset or Worsening Macular Edema - 1/12/2006
• Rosuvastatin (Crestor) - Myopathy and Rhabdomyolysis in Asian-Americans at 40 mg Dose - 3/3/2005
• Rotarix (Rotavirus Vacine, Live, Oral) - FDA Recommends Resuming Use - 5/18/2010
• Rugby Natural Iron Supplement (ferrous sulfate 325 mg) Tablets Recalled by Advance Pharmaceutical – May Contain Meclizine Tablets - 01/18/2013
• Salagen (pilocarpine) and Selegiline (Eldepryl) Name Confusion - 3/6/2006
• Salivart Oral Moisturizer Recall - 3/7/2007
• Sanofi Pasteur Pediatric H1N1 Vaccine in Pre-filled Syringes - Non-Safety-Related Voluntary Recall - 12/24/2009
• Sanofi-Aventis Medications Stolen - Verify Drug Pedigrees - 7/27/2009
• Saquinavir (Fortovase, Invirase) plus ritonavir (ritonavir boosted saquinavir) interacts with rifampin – increased liver toxicity reported - 2/10/2005
• Saquinavir (Invirase) and Ritonavir (Norvir): Potential Risk of Cardiac Arrhythmias - 10/22/2010
• Saratoga Therapeutics LLC Recalls ebA Multivitamin Due To Undeclared Milk Products - 4/30/2013
• Sargramostim (Leukine) Liquid Formulation Withdrawn from Market; Special Access Program for Powder Formulation - 3/25/2008
• Schedule II Controlled Substances - Changes a Pharmacist May Make to Written Prescriptions - Utah Law Update - 5/24/2010
• Sedative-Hypnotic Labeling Revisions - 3/15/2007
• Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy and the Risk of Persistent Pulmonary Hypertension of the Newborn (PPHN) - 1/6/2012
• Serotonin Syndrome With Triptans Plus SSRIs or SNRIs - 7/20/2006
• Sevoflurane (Ultane) – Fire Danger when Used with Desiccated Carbon Dioxide Absorbent - 11/21/2003
• Shipment of Chiron's Influenza Virus Vaccine (Fluvirin) Delayed - 9/2/2004
• Sibutramine Hydrochloride (Meridia) Withdrawn from Market Due to Increased Risk of Cardiovascular Events - 10/11/2010
• Sildenafil (Revatio®) - Risk of Increased Mortality in Pediatric Patients - 9/7/2012
• Similac (Abbott) Powder Infant Formulas - Recall - 9/27/2010
• SimplyThick® - Necrotizing Enterocolitis in Premature Infants - 5/24/2011
• Simvastatin Products (Zocor, Vytorin, Simcor) and Muscle Injury: New Labeling Changes - 12/16/2011
• Simvastatin products (Zocor, Zetia, Simcor, generic) and Amiodarone (Cordarone, Pacerone, generic) - Potentially Serious Interaction - 8/11/2008
• Simvastatin/Ezetimibe (Vytorin) and Ezetimibe (Zetia) and Increased Risk for Cancer of Safety Review - 12/24/2009
• Sirolimus (Rapamune®) - Effect of Different Assays on Therapeutic Drug Monitoring - 1/13/2010
• Sirolimus (Rapamune®) - Safety in Liver Transplant Patients - 6/15/2009
• Sitagliptin (Januvia) and sitagliptin/metformin (Janumet) - Reports of Acute Pancreatitis - 9/29/2009
• Skin Products May Contain Mercury, a Toxic Metal - 3/16/2012
• Sodium Bicarbonate Injection - Recall Due to Particulates - 12/29/2010
• Sodium Chromate Cr-51 Injection Recall - 7/13/2009
• Sodium Polystyrene Sulfonate - Recall Due to Contamination with Yeast - 7/17/2008
• Sodium Thiosulfate Injection - Recall Due to Particulates - 2/7/2011
• Soladek Vitamin Solution May Contain Toxic Amounts of Vitamins A and D - 3/29/2011
• SSRI Treatment During Pregnancy - 7/20/2006
• STARCAPS Diet System Capsules May Contain Bumetanide - 12/1/2008
• Stealth Powdered Dietary Supplements - Recall due to possible Salmonella - 7/10/2009
• Sterile Lubricating Jelly - Recall Due to Potentially Unsterile Product - 2/17/2011
• Steroid Products Sold Illegally as Dietary Supplements - 3/14/2006
• Stimulant Medications for Attention-Deficit/Hyperactivity Disorder – Cardiovascular Safety Review in Adults - 12/14/2011
• Stimulant Medications for Attention-Deficit/Hyperactivity Disorder – Safety Review in Children and Young Adults – Update - 1/6/2012
• Suboxone® (buprenorphine and naloxone) Sublingual Tablets:
  Voluntary Discontinuation by Manufacturer - 10/2/2012
• Surgiflo® Hemostatic Products Recalled by Ethicon - 12/14/2012
• Tamsulosin (Flomax) Associated with Intraoperative Floppy Iris Syndrome - 11/23/2005
• Tegaserod (Zelnorm) - Discontinued, No Longer Available Through Treatment Investigational New Drug Protocol- UPDATE - 4/3/2008
• Tegaserod Maleate (Zelnorm®) Associated with Severe Diarrhea and Rare Ischemic Colitis - 4/28/2004
• Telaprevir (Incivek) is Associated with Severe Skin Reactions When Used
  in Combination with Peginterferon Alfa and Ribavirin for Hepatitis C - 12/21/2012
• Telithromycin (Ketek) Updated Warnings - 3/27/2007
• Terbutaline Injection and Tablets- New Contraindication for Prolonged Treatment of Preterm Labor - 2/22/2011
• Testosterone Gel Products and Inadvertent Exposure in Children - 5/8/2009
• Teva Recalls Flutamide Capsules due to Potential Presence of Imatinib Mesylate Capsule - 1/30/2012
• The Compounding Shop Recalls All Sterile Compounded Products Due to Concerns Regarding Sterility and Quality Control - 5/9/2013
• Tiagabine (Gabitril) can cause seizures in patients without epilepsy - 2/23/2005
• Tigecycline (Tygacil®) Reformulation - 8/8/2007
• Tigecycline (Tygacil) and Increased Mortality Risk - 9/2/2010
• Tinzaparin - Increased Risk of Mortality - Ongoing Safety Analysis - 12/31/2008
• Tiotropium (Spiriva) and Risk of Stroke - Ongoing Safety Review UPDATED - 10/8/2008
• Tipranavir (Aptivus) Associated With Intracranial Hemorrhage - 7/6/2006
• Tizanidine (Zanaflex) - Contraindicated with Fluvoxamine or Ciprofloxacin - 4/12/2007
• Tolvaptan (Samsca) Drug Warning: Labeling Changes Due to Risk of Hepatic Injury - UPDATE - 05/07/2013
• Topical Anesthetic Agents for Medical and Cosmetic Procedures - Potentially Fatal Adverse Effects UPDATED - 6/29/2009
• Topical Hair Regrowth Products from Perfect Images Solutions - Recalled Due to Presence of Unapproved Drugs - 1/23/2012
• Topical Muscle and Joint Pain Relievers Associated with Chemical Burns - 9/14/2012
• Topiramate (Topamax) - Use During Pregnancy May Increase Risk of Cleft Lip or Cleft Palate - 3/7/2011
• Topiramate (Topamax) 100 mg tablets - Recall Due to Musty Odor - 4/15/2011
• Toprol-XL® (metoprolol succinate) extended release tablets – Name confusion - 9/28/2005
• Total Body Formula and Total Body Mega Formula - High Selenium Concentrations UPDATED - 6/24/2009
• Tramadol (Ultram, Ultracet) - Label Updates - 5/25/2010
• Tramadol injection - Typographical Error in the Handbook on Injectable Drugs - 1/5/2009
• Transdermal Patches with Metallic Backings - Risk of Burns if Worn During Magnetic Resonance Imaging Scans - 12/20/2010
• Trastuzumab (Herceptin) and Bacteriostatic Water for Injection Diluent Vials - Potential Vial Damage - 7/11/2008
• Trastuzumab (Herceptin) Increases Risk of Cardiotoxicity - 9/6/2005
• Trazodone (Desyrel, generic) interactions with CYP3A4 inhibitors and carbamazepine - 5/12/2004
• Trilipix® (Fenofibric Acid) - Labeling Changes Due to Inability to Lower Risk of Cardiovascular Events in the ACCORD Trial - 11/10/2011
• Trimethobenzamide Suppositories - Discontinued Due to Lack of Efficacy - 4/9/2007
• Tumor Necrosis Factor (TNF) α Blocking Agents - Increased Risk of Lymphoma and Other Malignancies - 10/15/2004
• Tumor Necrosis Factor (TNF) Blocking Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], golimimumab [Simponi], infliximab [Remicade])-Risk of Delayed Diagnosis of Opportunistic Infections - 6/30/2009
• Tumor Necrosis Factor-alpha Blockers - Boxed Warnings Updated with Information on Legionella and Listeria Infection Risk - 9/8/2011
• Tylenol Infant Formula Oral Suspension – Recall Due to SimpleMeasure Dosing System Problems - 2/17/2012
• Tylenol® Extra Strength Caplets - Recall Due To Unusual Odor - 7/1/2011
• Typhoid Vi Polysaccharide Vaccine (Typhim Vi)
  – Voluntary Recall of Prefilled Syringes and Multidose Vials - 10/3/2012
• Typographical Errors in the Handbook on Injectable Drugs – Esomeprazole Sodium Concentration Incorrect in Esomeprazole Sodium Monograph - 04/09/2013
• Typographical Errors in the Handbook on Injectable Drugs - Furosemide Concentration Incorrect in Diazepam and Digoxin Monographs, Doxorubicin Stability Correction - 2/13/2012
• Ultram ER Voluntary Recall - 1/14/2009
• Unapproved and Misbranded Drugs for Prevention and Treatment of STDs Marketed over the Internet - 3/7/2008
• Unapproved Compounded Inhalation Solutions May Not Be Safe - 8/11/2006
• Utah Medicaid Preferred Drug List Update - 5/19/2009
• Vagifresh Ball, Vagifresh Gel, and Female One - Products Recalled - 1/23/2012
• Valdecoxib (Bextra®) cardiovascular risk and severe skin reactions - 12/14/2004
• Valdecoxib (Bextra) Associated with Hypersensitivity Reactions - 11/13/2002
• Valganciclovir (Valcyte) - New Pediatric Dosing Recommendations - 9/16/2010
• Valproate Products Contraindicated in Pregnant Patients for Migraine Prophylaxis Due to Decreased IQ in Children Exposed In Utero - 5/9/2013
• Valproate Products and Risk of Impaired Cognitive Development in Children Due to Prenatal Exposure - 7/1/2011
• Valproic Acid Derivatives (valproate sodium [Depacon], valproic acid [Depakene, Stavzor], divalproex sodium [Depakote, Depakote CP, Depakote ER]) and Birth Defect Risk - 12/4/2009
• Vapor Patch Voluntary Recall - Triaminic Vapor Patch and WellPatch Cough & Cold Soothing Vapor Pads - 8/2/2006
• Varenicline (Chantix®) Safety Alert – Cardiovascular Adverse Events - UPDATE - 12/13/2012
• Varenicline (Chantix) - Neuropsychiatric Events and Suicidality Warnings added to the Prescribing Information - 7/1/2009
• Vasopressin injection - Typographical Error in the Handbook on Injectable Drugs - 12/8/2010
• Vasopressin Injection USP, Multiple Dose Vials - Voluntary Recall Due to Potential for Reduced Potency - 8/4/2011
• Vecuronium Bromide Injection 20 mg Vial – Voluntary Recall Due To Particulate Matter - 7/2/2012
• Vecuronium Bromide for Injection Recall by Hospira - 2/9/2009
• Venlafaxine (Effexor®/Effexor XR®) - Overdose Risk - 10/30/2006
• Venom Hyperdrive dietary supplement contains undeclared sibutramine - 1/29/2009
• Vicks Sinex Nasal Spray - Recall of Specific Lots by Procter & Gamble - 11/20/2009
• Vita Breath Dietary Supplement - May Contain Hazardous Lead Concentrations - 5/3/2010
• Vitamin D Supplements - Dosing Errors in Infants - 6/16/2010
• Warfarin - Pharmacogenomic Labeling Changes - 8/20/2007
• Warfarin (Coumadin) 1 mg Tablets in Blister Packs - Recall - 7/14/2010
• Warfarin 5 mg tablets - Voluntary Recall of a Single Lot of Coumadin 5 mg Tablets - 5/5/2011
• Warfarin Sodium (Coumadin®) - Patient Medication Guide and Black Box Warning - 10/11/2006
• Warfarin Sodium (Jantoven) 3 mg Tablets - Upsher-Smith Recall Expanded to Include Amantadine, Amlodipine, Baclofen, Bethanecol, Fluoxymesterone (Androxy), Oxybutynin, and Warfarin - 2/24/2011
• Weight Loss Products Containing Undeclared Active Ingredients - 12/27/2010
• Xyrem® (sodium oxybate) Updated Labeling – New Warnings and Contraindication - 12/17/2012
• Zanamivir (Relenza) - Potentially Fatal if Nebulized - 10/9/2009
• Zhen De Shou Dietary Supplement Contains Undeclared Sibutramine - 12/1/2008
• Zicam Extreme Congestion Relief Nasal Gel Recalled
  due to Presence of Burkholderia Cepacia - 12/19/2012
• Zicam Cold Remedy Nasal Products Associated with Loss of Sense of Smell - 6/16/2009
• Ziprasidone (Geodon) and Fluoroquinolones – Increased Risk of QT Interval Prolongation with Combined Use - Dec 2003
• Zoledronic Acid Contraindicated in Patients with Renal Dysfunction - 9/2/2011
• Zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) Dosing Change: Lower Recommended Doses - 01/16/2013
• Zonisamide (Zonegran® and Generics) - Risk of Metabolic Acidosis - 2/23/2009
• Zyvox (linezolid) and Psychiatric Medications Interaction - 10/21/2011